Knowledge Distillery

Cerebral Venous Sinus Thrombosis (CVST) as a part of the thrombosis and thrombocytopenia syndrome is a rare adverse drug reaction of SARS-CoV-2…

Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in multiple sclerosis (MS) subjects due to their immunomodulating disease…

Cognitive decline is a recognized manifestation of long COVID, even among patients who experienced mild disease. However, there is no evidence…

The objective of this study was to understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis…

In patients with severe coronavirus disease 2019 (COVID-19), disorders of consciousness (COVID-DoC) have emerged as a serious complication. The…

Patients hospitalised with COVID-19 are at risk for thrombotic events after discharge; the role of extended thromboprophylaxis in this population is…

Dysregulated inflammation is associated with poor outcomes in COVID-19. In this study the authors aimed to assess the efficacy of namilumab (a…

This study investigated the prevalence of long-term musculoskeletal post-COVID pain and their risk factors in a large cohort of COVID-19 survivors. A…

The COVID-19 pandemic has affected millions of individuals worldwide. The global scientific effort to design an effective vaccine against this virus…

In this paper the authors review the literature on movement disorders in the context of the COVID-19 pandemic. First, there are a variety of transient…

Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has witnessed a devastating global pandemic, with more than 238…

In this correspondence, Zhao et al. report the first case of COVID-19 initially presenting with acute Guillain-Barré syndrome (GBS) suggesting a…